Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Melphalan × Clear all

Sponsor

Conditions

Multiple Myeloma 92 Lymphoma 41 Hodgkin Disease 37 Myelodysplastic Syndromes 36 Lymphoma, Non-Hodgkin 36 Leukemia, Myeloid, Acute 34 Leukemia 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia, Lymphocytic, Chronic, B-Cell 23 Neoplasms, Plasma Cell 20 Lymphoma, Mantle-Cell 19 Lymphoma, Follicular 19 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, B-Cell, Marginal Zone 14 Burkitt Lymphoma 14 Myeloproliferative Disorders 12 Leukemia, Myeloid, Accelerated Phase 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Immunoglobulin Light-chain Amyloidosis 12 Recurrence 11 Primary Myelofibrosis 11 Hematologic Neoplasms 11 Congenital Abnormalities 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myelomonocytic, Juvenile 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Chronic-Phase 10 Lymphoma, T-Cell, Cutaneous 9 Dendritic Cell Sarcoma, Interdigitating 8 Blast Crisis 8

Interventions

Prednisone 90 Docetaxel 77 Leuprolide 68 enzalutamide 56 Abiraterone Acetate 55 bicalutamide 40 Goserelin 40 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 36 Radiotherapy 30 abiraterone 20 apalutamide 19 sipuleucel-T 18 luprolide acetate gel depot 18 gallium 68 PSMA-11 18 Gonadotropin-Releasing Hormone 18 Radiosurgery 16 Magnetic Resonance Spectroscopy 16 Triptorelin Pamoate 15 Androgen Antagonists 15 cabazitaxel 14 Radiotherapy, Intensity-Modulated 13 pembrolizumab 12 Prednisolone 12 Dexamethasone 12 Brachytherapy 12 cabozantinib 11 Radiation 11 Dutasteride 11 Carboplatin 11 radium Ra 223 dichloride 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡